SPX3,802.67+17.29 0.46%
DIA308.85+1.03 0.33%
IXIC11,088.51+59.78 0.54%

Immunome Enrolls First Patient in Phase 1b Trial of COVID-19 Treatment Candidate

MT Newswires · 06/09/2022 06:08

Please log in to view news